These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12490379)

  • 1. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features.
    Dailey LA; Schmehl T; Gessler T; Wittmar M; Grimminger F; Seeger W; Kissel T
    J Control Release; 2003 Jan; 86(1):131-44. PubMed ID: 12490379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Following the concentration of polymeric nanoparticles during nebulization.
    Beck-Broichsitter M; Knuedeler MC; Schmehl T; Seeger W
    Pharm Res; 2013 Jan; 30(1):16-24. PubMed ID: 22806406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions.
    Beck-Broichsitter M; Knuedeler MC; Oesterheld N; Seeger W; Schmehl T
    Int J Pharm; 2014 Jan; 459(1-2):23-9. PubMed ID: 24286921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers.
    Beck-Broichsitter M; Kleimann P; Schmehl T; Betz T; Bakowsky U; Kissel T; Seeger W
    Eur J Pharm Biopharm; 2012 Oct; 82(2):272-80. PubMed ID: 22820646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
    Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
    Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic aging of degradable nanosuspension ameliorates vibrating-mesh nebulizer performance.
    Dalla-Bona AC; Schmehl T; Gessler T; Seeger W; Beck-Broichsitter M
    Drug Dev Ind Pharm; 2015; 41(10):1704-9. PubMed ID: 25519975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of nebulized buparvaquone nanosuspensions--effect of nebulization technology.
    Hernández-Trejo N; Kayser O; Steckel H; Müller RH
    J Drug Target; 2005; 13(8-9):499-507. PubMed ID: 16332575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design principles of liquid nebulization devices currently in use.
    Rau JL
    Respir Care; 2002 Nov; 47(11):1257-75; discussion 1275-8. PubMed ID: 12425742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics.
    Lehofer B; Bloder F; Jain PP; Marsh LM; Leitinger G; Olschewski H; Leber R; Olschewski A; Prassl R
    Eur J Pharm Biopharm; 2014 Nov; 88(3):1076-85. PubMed ID: 25460154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.
    Dailey LA; Kleemann E; Wittmar M; Gessler T; Schmehl T; Roberts C; Seeger W; Kissel T
    Pharm Res; 2003 Dec; 20(12):2011-20. PubMed ID: 14725368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of Polymer Coatings on Nebulizer Membranes During Aerosol Generation.
    Beck-Broichsitter M
    J Pharm Sci; 2019 Nov; 108(11):3750-3754. PubMed ID: 31473213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
    Nasr M; Najlah M; D'Emanuele A; Elhissi A
    Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration.
    Phipps PR; Gonda I
    Chest; 1990 Jun; 97(6):1327-32. PubMed ID: 2347217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior of nebulizing solutions and suspensions.
    Dahlbäck M
    J Aerosol Med; 1994; 7(Suppl 1):S13-8. PubMed ID: 10147076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers.
    McCallion ON; Taylor KM; Thomas M; Taylor AJ
    Pharm Res; 1995 Nov; 12(11):1682-8. PubMed ID: 8592670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfluorocarbon species and nebulizer type influence aerosolization rate and particle size of perfluorocarbon aerosol.
    Rüdiger M; Gregor T; Burkhardt W; Proquitté H; Wauer RR; Schmalisch G
    J Crit Care; 2004 Mar; 19(1):42-7. PubMed ID: 15101005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating mesh nebulizer.
    Rao N; Kadrichu N; Ament B
    J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):295-302. PubMed ID: 20455771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosol production and aerosol droplet size distribution during mechanical ventilation (IPPV) with a new ultrasonic nebulizer.
    Kemming GI; Kreyling W; Habler O; Merkel M; Kleen M; Welte M; Messmer K; Zwissler B
    Eur J Med Res; 1996 Apr; 1(7):321-7. PubMed ID: 9364032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.